Skip to main content
OpenTrials

Clinical trial condition

HER2-negative Breast Cancer

Explore clinical trials studying HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

108 public trials 54 recruiting studies
Refine in advanced search Browse all conditions

HER2-negative Breast Cancer trial results

Completed

Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer

NCT01705691

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • CCOP, Colorado Cancer Research Program, Inc. Denver, Colorado, United States
  • CCOP - Mount Sinai Medical Center Miami Beach, Florida, United States
  • Phoebe Putney Memorial Hospital Albany, Georgia, United States
  • Memorial Health University Medical Center Savannah, Georgia, United States
View all 20 locations
View Trial Details
Completed

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

NCT00733408

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations
  • Anchorage Oncology Centre Anchorage, Alaska, United States
  • Katmai Oncology Group Anchorage, Alaska, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Yuma Cancer Center Yuma, Arizona, United States
View all 17 locations
View Trial Details
Completed

Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

NCT02225470

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +9 more
Locations
  • 04 Eisai Trial Site Bengbu, Anhui, China
  • 37 Eisai Trial Site Hefei, Anhui, China
  • 01 Eisai Trial Site Beijing, Beijing Municipality, China
  • 03 Eisai Trial Site Beijing, Beijing Municipality, China
View all 35 locations
View Trial Details

Related conditions